|
1
|
Cai Y, Ruan J, Yao X, Zhao L and Wang B:
MicroRNA-187 modulates epithelial-mesenchymal transition by
targeting PTRF in non-small cell lung cancer. Oncol Rep.
37:2787–2794. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li L and Ma HQ: MicroRNA-216a inhibits the
growth and metastasis of oral squamous cell carcinoma by targeting
eukaryotic translation initiation factor 4B. Mol Med Rep.
12:3156–3162. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang J, Xu K, Shi L, Zhang L, Zhao Z, Xu
H, Liang F, Li H, Zhao Y, Xu X and Tian Y: Overexpression of
MicroRNA-216a suppresses proliferation, migration, and invasion of
glioma cells by targeting leucine-rich repeat-containing G
protein-coupled receptor 5. Oncol Res. 25:1317–1327. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liu B, Su F, Chen M, Li Y, Qi X, Xiao J,
Li X, Liu X, Liang W, Zhang Y and Zhang J: Serum miR-21 and
miR-125b as markers predicting neoadjuvant chemotherapy response
and prognosis in stage II/III breast cancer. Hum Pathol. 64:44–52.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tang X, Tang J, Liu X, Zeng L, Cheng C,
Luo Y, Li L, Qin SL, Sang Y, Deng LM and Lv XB: Downregulation of
miR-129-2 by promoter hypermethylation regulates breast cancer cell
proliferation and apoptosis. Oncol Rep. 35:2963–2969. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu F, You X, Wang Y, Liu Q, Liu Y, Zhang
S, Chen L, Zhang X and Ye L: The oncoprotein HBXIP enhances
angiogenesis and growth of breast cancer through modulating FGF8
and VEGF. Carcinogenesis. 35:1144–1153. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Di YF, Li DC, Shen YQ, Wang CL, Zhang DY,
Shang AQ and Hu T: MiR-146b protects cardiomyocytes injury in
myocardial ischemia/reperfusion by targeting Smad4. Am J Transl
Res. 9:656–663. 2017.PubMed/NCBI
|
|
8
|
Makhdoumi P, Roohbakhsh A and Karimi G:
MicroRNAs regulate mitochondrial apoptotic pathway in myocardial
ischemia-reperfusion-injury. Biomed Pharmacother. 84:1635–1644.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Akhtar N and Haqqi TM: MicroRNA-199a*
regulates the expression of cyclooxygenase-2 in human chondrocytes.
Ann Rheum Dis. 71:1073–1080. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lin N, Li XY, Zhang HM, Yang Z and Su Q:
microRNA-199a-5p mediates high glucose-induced reactive oxygen
species production and apoptosis in INS-1 pancreatic β-cells by
targeting SIRT1. Eur Rev Med Pharmacol Sci. 21:1091–1098.
2017.PubMed/NCBI
|
|
11
|
Wu C, Jin B, Chen L, Zhuo D, Zhang Z, Gong
K and Mao Z: MiR-30d induces apoptosis and is regulated by the
Akt/FOXO pathway in renal cell carcinoma. Cell Signal.
25:1212–1221. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li X, Du N, Zhang Q, Li J, Chen X, Liu X,
Hu Y, Qin W, Shen N, Xu C, et al: MicroRNA-30d regulates
cardiomyocyte pyroptosis by directly targeting foxo3a in diabetic
cardiomyopathy. Cell Death Dis. 5:e14792014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ma X, Liu L and Meng J: MicroRNA-125b
promotes neurons cell apoptosis and Tau phosphorylation in
Alzheimer's disease. Neurosci Lett. 661:57–62. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Magnin E, Dumurgier J, Bouaziz-Amar E,
Bombois S, Wallon D, Gabelle A, Lehmann S, Blanc F, Bousiges O,
Hannequin D, et al: Alzheimer's disease cerebro-spinal fluid
biomarkers: A clinical research tool sometimes useful in daily
clinical practice of memory clinics for the diagnosis of complex
cases. Rev Med Interne. 38:250–255. 2017.(In French). View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-delta delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
An G, Liang S, Sheng C, Liu Y and Yao W:
Upregulation of microRNA-205 suppresses vascular endothelial growth
factor expression-mediated PI3K/Akt signaling transduction in human
keloid fibroblasts. Exp Biol Med (Maywood). 242:275–285. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yue X, Wang P, Xu J, Zhu Y, Sun G, Pang Q
and Tao R: MicroRNA-205 functions as a tumor suppressor in human
glioblastoma cells by targeting VEGF-A. Oncol Rep. 27:1200–1206.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Niu K, Shen W, Zhang Y, Zhao Y and Lu Y:
MiR-205 promotes motility of ovarian cancer cells via targeting
ZEB1. Gene. 574:330–336. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Guan B, Li Q, Shen L, Rao Q, Wang Y, Zhu
Y, Zhou XJ and Li XH: MicroRNA-205 directly targets Krüppel-like
factor 12 and is involved in invasion and apoptosis in basal-like
breast carcinoma. Int J Oncol. 49:720–734. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen JQ, Papp G, Poliska S, Póliska S,
Szabó K, Tarr T, Bálint BL, Szodoray P and Zeher M: MicroRNA
expression profiles identify disease-specific alterations in
systemic lupus erythematosus and primary Sjögren's syndrome. PLoS
One. 12:e01745852017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Williams AE, Choi K, Chan AL, Lee YJ,
Reeves WH, Bubb MR, Stewart CM and Cha S: Sjögren's
syndrome-associated microRNAs in CD14(+) monocytes unveils targeted
TGFβ signaling. Arthritis Res Ther. 18:952016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Alevizos I and Illei GG: MicroRNAs in
Sjögren's syndrome as a prototypic autoimmune disease. Autoimmun
Rev. 9:618–621. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tandon M, Gallo A, Jang SI, Illei GG and
Alevizos I: Deep sequencing of short RNAs reveals novel microRNAs
in minor salivary glands of patients with Sjögren's syndrome. Oral
Dis. 18:127–131. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mi L, Chen Y, Zheng X, Li Y, Zhang Q, Mo D
and Yang G: MicroRNA-139-5p suppresses 3T3-L1 preadipocyte
differentiation through notch and IRS1/PI3K/Akt insulin signaling
pathways. J Cell Biochem. 116:1195–1204. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Krishnan K, Steptoe AL, Martin HC,
Pattabiraman DR, Nones K, Waddell N, Mariasegaram M, Simpson PT,
Lakhani SR, Vlassov A, et al: miR-139-5p is a regulator of
metastatic pathways in breast cancer. RNA. 19:1767–1780. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mameli G, Arru G, Caggiu E, Niegowska M,
Leoni S, Madeddu G, Babudieri S, Sechi GP and Sechi LA: Natalizumab
therapy modulates miR-155, miR-26a and proinflammatory cytokine
expression in MS patients. PLoS One. 11:e01571532016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Maoa R, Zou F, Yang L, Lin S, Li Y, Ma M,
Yin P, Liang X and Liu Y: The loss of MiR-139-5p promotes
colitis-associated tumorigenesis by mediating PI3K/AKT/Wnt
signaling. Int J Biochem Cell Biol. 69:153–161. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xin Q, Li J, Dang J, Bian X, Shan S, Yuan
J, Qian Y, Liu Z, Liu G, Yuan Q, et al: miR-155 deficiency
ameliorates autoimmune inflammation of systemic lupus erythematosus
by targeting S1pr1 in Faslpr/lpr mice. J Immunol. 194:5437–5445.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Petry FR, Pelletier J, Bretteville A,
Morin F, Calon F, Hébert SS, Whittington RA and Planel E:
Specificity of anti-tau antibodies when analyzing mice models of
Alzheimer's disease: Problems and solutions. PLoS One.
9:e942512014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gratuze M, El Khoury NB, Turgeon A, Julien
C, Marcouiller F, Morin F, Whittington RA, Marette A, Calon F and
Planel E: Tau hyperphosphorylation in the brain of ob/ob mice is
due to hypothermia: Importance of thermoregulation in linking
diabetes and Alzheimer's disease. Neurobiol Dis. 98:1–8. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Laurents DV, Gorman PM, Guo M, Rico M,
Chakrabartty A and Bruix M: Alzheimer's Abeta40 studied by NMR at
low pH reveals that sodium 4,4-dimethyl-4-silapentane-1-sulfonate
(DSS) binds and promotes beta-ball oligomerization. J Biol Chem.
280:3675–3685. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li Y, Cai B, Shen L, Dong Y, Lu Q, Sun S,
Liu S, Ma S, Ma PX and Chen J: MiRNA-29b suppresses tumor growth
through simultaneously inhibiting angiogenesis and tumorigenesis by
targeting Akt3. Cancer Lett. 397:111–119. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Das S: Identification and targeting of
microRNAs modulating acquired chemotherapy resistance in Triple
negative breast cancer (TNBC): A better strategy to combat
chemoresistance. Med Hypotheses. 96:5–8. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Shen H, Li L, Yang S, Wang D, Zhong S,
Zhao J and Tang J: MicroRNA-29a contributes to drug-resistance of
breast cancer cells to adriamycin through PTEN/AKT/GSK3β signaling
pathway. Gene. 593:84–90. 2016. View Article : Google Scholar : PubMed/NCBI
|
